Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma

• Main Authors: Xu, Y, Peng, Z, Li, Z, Lu, M, Gao, J, Li, Y, Shen, L
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2020
• Subjects: antineoplastic agent; cisplatin; epidermal growth factor receptor kinase inhibitor; irinotecan; nimotuzumab; paclitaxel; scatter factor receptor; EGFR protein, human; epidermal growth factor receptor; MET protein, human; protein kinase inhibitor; adult; advanced cancer; Article; cancer center; cancer combination chemotherapy; cancer localization; cancer patient; cancer prognosis; cancer survival; clinical feature; controlled study; esophageal squamous cell carcinoma; female; histopathology; human; human tissue; immunohistochemistry; major clinical study; male; overall survival; phase 2 clinical trial (topic); prediction; protein expression; retrospective study; sex; university hospital; antagonists and inhibitors; Carcinoma, Squamous Cell; Esophageal Neoplasms; metabolism; pathology; prognosis; survival analysis; upregulation; Antineoplastic Agents; Female; Humans; Male; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Receptor, Epidermal Growth Factor; Survival Analysis; Up-Regulation
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181461
• Institution: National University of Singapore

10.1186/s12885-014-1001-3